UDG Healthcare (UDG) Rating Reiterated by N+1 Singer
N+1 Singer restated their hold rating on shares of UDG Healthcare (LON:UDG) in a research report released on Tuesday morning, MarketBeat.com reports.
Several other analysts also recently issued reports on the company. Peel Hunt boosted their price objective on UDG Healthcare from GBX 840 ($11.25) to GBX 860 ($11.52) and gave the stock an add rating in a report on Tuesday, October 31st. Numis Securities downgraded UDG Healthcare to a reduce rating and set a GBX 765 ($10.25) price objective on the stock. in a report on Thursday, November 9th. Liberum Capital restated a hold rating and set a GBX 884 ($11.84) price objective on shares of UDG Healthcare in a report on Wednesday, November 15th. Finally, Jefferies Group boosted their price objective on UDG Healthcare from GBX 830 ($11.12) to GBX 855 ($11.45) and gave the stock a hold rating in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company. The company presently has an average rating of Hold and an average target price of GBX 831.43 ($11.13).
Shares of UDG Healthcare (LON:UDG) opened at GBX 857 ($11.48) on Tuesday. UDG Healthcare has a twelve month low of GBX 632.50 ($8.47) and a twelve month high of GBX 963 ($12.90).
ILLEGAL ACTIVITY WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/12/02/udg-healthcare-udg-rating-reiterated-by-n1-singer.html.
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Stock Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related stocks with our FREE daily email newsletter.